跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXAR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VAXAR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
VAXAR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 27, 2021
Approval ID
c3c02e5e9a89259b
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
c3c02e5e9a89259b
Drug Cima Aemps Name
VAXAR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86109
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2021-07-27
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
ROSUVASTATINA CALCICA
41,6000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 27, 2021
Approval ID
c3c02e5e9a89259b
Type
Standard
Back to CIMA-AEMPS Approvals